EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Building Quality Control for Molecular Assays in the Global Measles and Rubella Laboratory Network

Bettina Bankamp, Raydel Anderson iD, Lijuan Hao iD, Elena Lopareva, Min-Hsin Chen iD, Gimin Kim, R Suzanne Beard, Yoshio Mori, Noriyuki Otsuki, Akihido Ryo, Paul A Rota

Vaccines · 23.07.2024 · 12 (8) · 824

DOI: 10.3390/vaccines12080824 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Vaccines, online erschienen am 23.07.2024. Verfasst von Bettina Bankamp und 10 weiteren Autor:innen. Beteiligte Einrichtung: Centers for Disease Control and Prevention, 1600 Clifton Road N.E., Atlanta, GA 30329, USA. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

More than 100 laboratories in the World Health Organization Global Measles and Rubella Laboratory Network (GMRLN) perform nucleic acid-based methods for case confirmation of measles or rubella infections and/or strain surveillance (genotyping). The quality of laboratory data is critical to ensure that diagnostic results and country reports to regional verification committees are based on accurate data. A molecular External Quality Assurance (mEQA) program was initiated by the US-CDC in 2014 to evaluate the performance of laboratories in the network. The inclusion of testing for measles and rubella viruses, with a focus on detection and genotyping, plus the diversity of assays and platforms employed required a flexible and comprehensive proficiency testing program. A stepwise introduction of new evaluation criteria gradually increased the stringency of the proficiency testing program, while giving laboratories time to implement the required changes. The mEQA program plays an important role in many processes in the GMRLN, including informing plans for the training of laboratory staff, access to reagents, and the submission of sequence data to global databases. The EQA program for Local Public Health Institutes in Japan is described as an example for national mEQA programs. As more laboratories initiate molecular testing, the mEQA will need to continue to expand and to adapt to the changing landscape for molecular testing.

Schlagwörter

Stichwörter der Autor:innen

external quality assessmentgenotypingmeaslesrubella

Autor:innen und Institutionen

  • Centers for Disease Control and Prevention, 1600 Clifton Road N.E., Atlanta, GA 30329, USA.
  • Department of Virology III, National Institute of Infectious Diseases, Tokyo 208-0011, Japan.

ORCID-Profile: Raydel Anderson, Lijuan Hao, Min-Hsin Chen

Zitieren

APA

Bankamp, B., Anderson, R., Hao, L., Lopareva, E., Chen, M. H., Kim, G., Beard, R. S., Mori, Y., Otsuki, N., Ryo, A., & Rota, P. A. (2024). Building Quality Control for Molecular Assays in the Global Measles and Rubella Laboratory Network. Vaccines, 12(8), 824. https://doi.org/10.3390/vaccines12080824

Vancouver

Bankamp B, Anderson R, Hao L, Lopareva E, Chen MH, Kim G, et al. Building Quality Control for Molecular Assays in the Global Measles and Rubella Laboratory Network. Vaccines. 2024;12(8):824. doi:10.3390/vaccines12080824

BibTeX
@article{Bankamp2024,
  author = {Bankamp, Bettina and Anderson, Raydel and Hao, Lijuan and Lopareva, Elena and Chen, Min-Hsin and Kim, Gimin and Beard, R Suzanne and Mori, Yoshio and Otsuki, Noriyuki and Ryo, Akihido and Rota, Paul A},
  title = {Building Quality Control for Molecular Assays in the Global Measles and Rubella Laboratory Network},
  journal = {Vaccines},
  year = {2024},
  volume = {12},
  number = {8},
  pages = {824},
  doi = {10.3390/vaccines12080824}
}
Kostenlos starten →